Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma.
OBJECTIVE
To study the time course of corticosteroid binding-globulin (CBG) level and the free cortisol index (FCI) in comparison with total cortisol and ACTH concentrations during acute and prolonged critical illness.


METHODS
Prospective observational clinical study.


METHODS
Twenty-bed medical/surgical intensive care unit.


METHODS
Thirty patients with septic shock, eight patients with multitrauma, and forty healthy control subjects.


RESULTS
During 14 days or until discharge/death, we serially measured serum concentrations of CBG, cortisol, TNF-alpha, IL-6, plasma ACTH immunoreactivity, and the FCI (=cortisol/CBG x 100). We also recorded haemodynamic parameters, APACHE II, ISS, SOFA scores, shock duration, inotrope use, and ICU mortality. In both groups we found markedly decreased CBG levels in the early phase (septic shock: 17.5+/-5.9, and trauma: 16.1+/-2.3 mg/l) in comparison with controls (37.3+/-5.3 mg/l). The FCI was high in this early phase (septic shock: 7.2+/-2.7; trauma: 6.5+/-1.3; controls: 1.25+/-0.76). During follow-up, CBG levels significantly increased, reaching normal levels from day 7 on. The FCI showed an opposite biphasic pattern, with near-normalising FCI values during the second phase. Regression analysis showed a negative correlation between CBG and IL-6 levels (rs=-0.63; P<0.05), but no relation between CBG concentrations and disease severity, shock duration or death was found.


CONCLUSIONS
We found extremely low CBG levels in early stage septic shock and multitrauma. These dramatic changes are reflected in a concomitant higher FCI, indicating a higher free cortisol level. A second phase displays increasing and normalising CBG levels, independent from clinical parameters. We believe that CBG plays an active role in the glucocorticoid response to severe stress and in the regulation of cortisol availability to target tissues.
Beishuizen
A
A
Department of Clinical Chemistry, Medical Spectrum Twente, PO 50.000, 7500 KA, Enschede, Netherlands.
Thijs
L G
LG
Vermes
I
I
D018806:APACHE; D000208:Acute Disease; D000324:Adrenocorticotropic Hormone / Q000097:blood*; D016022:Case-Control Studies; D002908:Chronic Disease; D016638:Critical Illness; D018450:Disease Progression; D005260:Female; D006439:Hemodynamics; D017052:Hospital Mortality; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D008875:Middle Aged; D009104:Multiple Trauma / Q000145:classification / Q000378:metabolism* / Q000401:mortality / Q000503:physiopathology; D011446:Prospective Studies; D012044:Regression Analysis; D012772:Shock, Septic / Q000145:classification / Q000378:metabolism* / Q000401:mortality / Q000503:physiopathology; D013997:Time Factors; D014156:Transcortin / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D000324:Adrenocorticotropic Hormone; D014156:Transcortin; D006854:Hydrocortisone